Tilfrinib

Tilfrinib is a potent and selective Brk (Breast Tumor Kinase) inhibitor with an IC50 of 3.15 nM. It demonstrates anti-proliferative activity in cellular assays and has shown anti-tumor efficacy in vivo, making it a valuable tool for oncology research targeting Brk-dependent signaling pathways.

Product Specifications

CAS Number

1600515-49-8

Product Name Alternative

BRK, Brk, Tilfrinib

Field of Research

Cardiovascular Research, Signal Transduction

Purity

99.54% (May vary between batches)

Solubility

DMSO:112.5 mg/mL (408.65 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (14.53 mM)

Smiles

Oc1cccc (Nc2ccnc3[nH]c4ccccc4c23) c1

Molecular Formula

C17H13N3O

Molecular Weight

275.3

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

Oneq-V272-100R 100 Reactions

Grass carp reovirus One-Step PCR kit

View Details

NBP2-81027AF647 0.1 mL

Human Monoclonal hapten 4-hydroxy-3-nitrophenyl acetyl (NP) Antibody (B1-8) [Alexa Fluor 647]

View Details

CS-T-103583 1 Each

Veratrole-13C6

View Details

SAF6931 1 Each

Corrosive Safety Counter Cabinet 2 comp 2 Door 115L

View Details

RC223738L3V 200 µL

OSBP2 (NM_030758) Human Tagged ORF Clone Lentiviral Particle

View Details

507823 100 µg

CD1A discontinued

View Details